(Q40172518)

18 September 2017

1 reference

title

Clinical disorders of aldosterone metabolism (English)

1 reference

18 September 2017

D. C. Batlle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368159

9 October 2023

N. A. Kurtzman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368159

9 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6368159

9 October 2023

publication date

1 May 1984

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0011502984900166?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

https://api.elsevier.com/content/article/PII:0011502984900166?httpAccept=text/plain

9 October 2023

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

9 October 2023

1 reference

18 September 2017

volume

30

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

1-55

1 reference

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

18 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease

9 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog

9 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The critical role of the adrenal gland in the renal regulation of acid-base equilibrium during chronic hypotonic expansion. Evidence that chronic hyponatremia is a potent stimulus to aldosterone secretion

9 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone

9 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Dopaminergic control of serum potassium

9 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

A functional comparison of the cortical collecting tubule and the distal convoluted tubule

9 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Effects of aldosterone and potassium-sparing diuretics on electrical potential differences across the distal nephron

9 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Effect of actinomycin D on aldosterone-mediated changes in electrolyte excretion

9 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The effect of DOCA on electrolyte balance in normal man and its relation to sodium chloride intake

9 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Acidification of luminal fluid by the rabbit cortical collecting tubule perfused in vitro

9 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Ion transport by the cortical and outer medullary collecting tubule

9 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

On the mechanism of action of aldosterone on sodium transport: effects of inhibitors of RNA and of protein synthesis

9 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1

9 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Characteristics of stimulation of H+ transport by aldosterone in turtle urinary bladder

9 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro

9 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Aldosterone stimulation of acidification of urine by isolated urinary bladder of the Colombian toad

9 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy

9 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies

9 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Clinical and pathophysiologic spectrum of acquired distal renal tubular acidosis

9 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Mechanism of the metabolic acidosis of selective mineralocorticoid deficiency

9 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Renal acidosis and renal potassium handling in selective hypoaldosteronism

9 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Amelioration of Metabolic Acidosis with Fludrocortisone Therapy in Hyporeninemic Hypoaldosteronism

9 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Influence of aldosterone on renal ammonia production

9 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism

9 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The effect of uncomplicated potassium depletion on urine acidification

9 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Relationship of renal ammonia production and potassium homeostasis

9 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

ELECTROLYTE BALANCE STUDIES IN ADRENALECTOMIZED DOGS WITH PARTICULAR REFERENCE TO THE EXCRETION OF SODIUM.

9 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Dynamic aspects of sodium metabolism in experimental adrenal insufficiency using radioactive sodium

9 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

[Influence of dexamethasone on water and electrolyte excretion in adrenalectomized rats]

9 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

An extrarenal mechanism of potassium adaptation

9 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Regulation of extrarenal potassium homeostasis by adrenal hormones in rats

9 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Effect of insulinopenia and adrenal hormone deficiency on acute potassium tolerance

9 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.

9 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Association of Hypotension With Hyperreninemic Hypoaldosteronism in the Critically Ill Patient

9 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypoaldosteronism; a clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks

9 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone

9 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

ISOLATED ANALDOSTERONISM. I. CLINICAL ENTITY, WITH MANIFESTATIONS OF PERSISTENT HYPERKALEMIA, PERIODIC PARALYSIS, SALT-LOSING TENDENCY, AND ACIDOSIS

9 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency

9 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Isolated hypoaldosteronism in adults. A renin-deficiency syndrome

9 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypoaldosteronism with otherwise intact adrenocortical function, resulting in a characteristic clinical entity

9 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia

9 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Selective Aldosterone Deficiency1

9 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.

9 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Big Renin and Biosynthetic Defect of Aldosterone in Diabetes Mellitus

9 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyporeninemia and hypoaldosteronism in diabetes mellitus

9 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Diabetic sclerosis of the renal juxtaglomerular apparatus

9 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Role of the Renin-Angiotensin-Aldosterone System in the Regulation of Plasma Potassium in Chronic Renal Disease

9 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The regulation of aldosterone secretion in anephric man

9 October 2023

51

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance

9 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The effects of alteration of plasma sodium and potassium concentration on aldosterone secretion

9 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Selective hypoaldosteronism with hyperreninemia in a diabetic patient

9 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease.

9 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension

9 October 2023

56

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyporeninemic Hypoaldosteronism in Diabetes Mellitus: Studies of the Autonomic Nervous System's Control of Renin Release

9 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension

9 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Indomethacin-induced hyperkalemia in three patients with gouty arthritis

9 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemia associated with indomethacin

9 October 2023

60

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism

9 October 2023

61

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Aldosterone Production by Isolated Glomerulosa Cells: Modulation of Sensitivity to Angiotensin II and ACTH by Extracellular Potassium Concentration

9 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs

9 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemia and Renal Tubular Acidosis Due to Renal Amyloidosis

9 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies

9 October 2023

67

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Acidification of the urine and increased ammonium excretion without change in acid-base equilibrium: sodium reabsorption as a stimulus to the acidifying process

9 October 2023

68

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

ALDOSTERONE SECRETION IN SEVERE RENAL FAILURE

9 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease

9 October 2023

70

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Primary adrenocortical carcinoma causing aldosteronism

9 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Anomalous Postural Aldosterone Response in Glucocorticoid-Suppressible Hyperaldosteronism

9 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Dexamethasone-suppressible hyperaldosteronism.

9 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone

9 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

On the pathogenesis of metabolic alkalosis in hyperaldosteronism

9 October 2023

76

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Water excrtion in potassium-deficient man

9 October 2023

77

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM

9 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity

9 October 2023

80

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Primary Aldosteronism with Suppressed Plasma Renin Activity Due to Bilateral Nodular Adrenocortical Hyperplasia

9 October 2023

81

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid Excess

9 October 2023

83

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The changing clinical spectrum of primary aldosteronism

9 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Location of Aldosterone-Producing Adenomas with131I-19-Iodocholesterol

9 October 2023

86

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

17-hydroxylation deficiency in man

9 October 2023

87

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

The adrenogenital syndrome

9 October 2023

89

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome

9 October 2023

90

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Pathogenesis of hypokalemic alkalosis in Cushing's syndrome

9 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity

9 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Carbenoxolone-induced hypokalaemia simulating Guillain-Barre syndrome

9 October 2023

96

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome

9 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology.

9 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis

9 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Chronic laxative-induced hyperaldosteronism and hypokalemia simulating Bartter's syndrome

9 October 2023

101

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Role of prostaglandins in the pathogenesis of Bartter's syndrome

9 October 2023

102

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects

9 October 2023

103

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Abnormal intracellular granules of the renal papilla in a child with potassium depletion (Bartter's syndrome) and renal tuberous sclerosis

9 October 2023

105

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin

9 October 2023

106

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of henle as a proximal cause of Bartter's syndrome

9 October 2023

109

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Magnesium supplementation in Bartter's syndrome

9 October 2023

110

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Prostaglandins and aspirin therapy in Bartter's syndrome

9 October 2023

111

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

9 October 2023

112

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Renin, Aldosterone, Body Fluid Volumes, and the Baroreceptor Reflex in the Development and Reversal of Goldblatt Hypertension in Conscious Dogs

9 October 2023

113

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Acute renovascular hypertension in conscious dogs. Interaction of the renin-angiotensin system and sympathetic nervous system in systemic hemodynamics and regional blood flow responses

9 October 2023

115

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

BIO-ASSAY OF CIRCULATING RENIN-LIKE PRESSOR MATERIAL BY ISOVOLEMIC CROSS CIRCULATION

9 October 2023

116

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Renal vascular hypertension and low plasma renin activity. Interrelationship of volume and renin in the pathogenesis of hypertension

9 October 2023

117

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Hypertension of renal origin: evidence for two different mechanisms

9 October 2023

118

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Reciprocation of Renin Dependency with Sodium Volume Dependency in Renal Hypertension

9 October 2023

119

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Reciprocal relation between renin dependency and sodium dependency in essential hypertension

9 October 2023

120

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Outpatient experience with saralasin

9 October 2023

121

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme Inhibitor

9 October 2023

122

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability

9 October 2023

123

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Chronic blockade of angiotensin II formation during sodium deprivation

9 October 2023

124

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Contribution of the Kidneys but not Adrenal Glands to the Acute Antihypertensive Effects of Captopril in Spontaneously Hypertensive Rats

9 October 2023

125

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis

9 October 2023

126

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

Nonsurgical treatment of severe hypertension due to renal-artery intimal fibroplasia by percutaneous transluminal angioplasty

9 October 2023

127

1 reference

https://api.crossref.org/works/10.1016/0011-5029(84)90016-6

9 October 2023

Identifiers

1 reference

release_et2gfgnwdbh5zefqtruhhhqmtq

18 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/et2gfgnwdbh5zefqtruhhhqmtq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference